Synergy Asset Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Synergy Asset Management's LLY Position: Q2 2026 in Review
Synergy Asset Management reduced its Eli Lilly (LLY) stake by 6.3% in Q2 2026, selling an estimated $359K and leaving 5,265 shares worth $6.31M. The position accounts for 0.6% of the portfolio, ranked #32.
Synergy Asset Management first reported a position in LLY in Q2 2024 and has held it in 9 quarters since. The position peaked at $42.3M in Q3 2025. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Synergy Asset Management held 5,265 shares of Eli Lilly worth $6.31M as of Q2 2026.
- Synergy Asset Management sold 351 Eli Lilly shares in Q2 2026, an estimated $359K.
- Eli Lilly made up 0.6% of Synergy Asset Management's portfolio in Q2 2026, its #32 holding.
- Synergy Asset Management first reported a position in Eli Lilly in Q2 2024 and has held it in 9 quarters since.
- Synergy Asset Management's Eli Lilly position peaked at $42.3M in Q3 2025.
- 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Synergy Asset Management's 13F filing for Q2 2026, filed 22 Jul 2026.